We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+13.4%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$1.67B
(+18%)
Cap. Flow
+$806M
Cap. Flow
% of AUM
7.42%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
678
New
211
Increased
171
Reduced
126
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ERF
Enerplus Corporation
ERF
|
+$91.2M |
| 2 |
TE Connectivity
TEL
|
+$81.6M |
| 3 |
Palo Alto Networks
PANW
|
+$78.9M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$75.6M |
| 5 |
Honeywell
HON
|
+$70.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$113M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
+$88.1M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$70.1M |
| 5 |
Synopsys
SNPS
|
+$64.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.5% |
| 2 | Technology | 22.75% |
| 3 | Industrials | 9.82% |
| 4 | Energy | 8.34% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$1.07T
| $247M | 2.28% |
317,824
+753
| +0.2% | +$536K |
|
|
2
TE Connectivity
TEL
$58.8B
| $215M | 1.98% |
1,483,569
+582,418
| +65% | +$81.6M |
|
3
Regeneron Pharmaceuticals
REGN
$68.8B
| $164M | 1.51% |
170,602
+512
| +0.3% | +$487K |
|
4
Ovintiv
OVV
$17.5B
| $161M | 1.49% |
3,110,099
-5,363
| -0.2% | -$244K |
|
5
Analog Devices
ADI
$181B
| $138M | 1.27% |
699,226
+70,323
| +11% | +$13.5M |
|
6
Avnet
AVT
$7.33B
| $133M | 1.22% |
2,681,386
+999,029
| +59% | +$46.8M |
|
7
Merck
MRK
$324B
| $129M | 1.19% |
976,017
+181,561
| +23% | +$22.4M |
|
8
Revolution Medicines
RVMD
$40.2B
| $122M | 1.13% |
3,797,148
+837,108
| +28% | +$24.8M |
|
9
Zimmer Biomet
ZBH
$17.7B
| $121M | 1.11% |
915,350
+358,631
| +64% | +$44.8M |
|
10
Meta Platforms (Facebook)
META
$1.51T
| $119M | 1.1% |
245,509
+3,386
| +1% | +$1.51M |
|
11
Roivant Sciences
ROIV
$25.2B
| $118M | 1.08% |
11,172,306
+5,020,539
| +82% | +$54.1M |
|
|
12
AbbVie
ABBV
$458B
| $116M | 1.07% |
638,393
-636,304
| -50% | -$110M |
|
|
ERF
13
DELISTED
Enerplus Corporation
ERF
| $110M | 1.01% |
+5,602,613
| New | +$91.2M |
|
|
PR
14
Permian Resources
PR
$17.9B
| $104M | 0.96% |
5,890,864
-4,244,201
| -42% | -$62.3M |
|
15
Amazon
AMZN
$2.5T
| $103M | 0.95% |
570,947
+4,649
| +0.8% | +$776K |
|
16
Snowflake
SNOW
$92.9B
| $101M | 0.93% |
626,368
+204,823
| +49% | +$39.7M |
|
17
L3Harris
LHX
$55.9B
| $100M | 0.92% |
469,926
+59,072
| +14% | +$12.4M |
|
18
Qorvo
QRVO
$7.63B
| $89.6M | 0.83% |
780,690
-182,257
| -19% | -$20.1M |
|
19
Emerson Electric
EMR
$82.9B
| $84.2M | 0.78% |
742,512
+74,921
| +11% | +$7.7M |
|
20
Keysight
KEYS
$54.5B
| $81.8M | 0.75% |
522,868
+395,792
| +311% | +$60.9M |
|
21
Johnson & Johnson
JNJ
$635B
| $79.4M | 0.73% |
501,919
-13,981
| -3% | -$2.23M |
|
|
22
Arthur J. Gallagher & Co
AJG
$63.7B
| $78.6M | 0.72% |
+314,492
| New | +$75.6M |
|
|
BPMC
23
DELISTED
Blueprint Medicines
BPMC
| $78.5M | 0.72% |
827,173
+12,700
| +2% | +$1.09M |
|
24
Expedia Group
EXPE
$31.2B
| $75.4M | 0.69% |
547,134
-43,965
| -7% | -$6.25M |
|
25
Pentair
PNR
$10.2B
| $74.6M | 0.69% |
872,550
+86,285
| +11% | +$6.54M |
|
Similar funds
KAS
PAM
TCIIS
Woodline Partners's Q1 2024 Portfolio in Review
As of Q1 2024, Woodline Partners held 678 positions worth $10.9B, up 18% from $9.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Woodline Partners deployed $806M of net new capital in Q1 2024, opening 211 new positions and adding to 171 existing holdings. Its largest new stake was Enerplus Corporation: 5,602,613 shares worth $110M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $110M trimmed.
- Woodline Partners's largest Q1 2024 buy was Enerplus Corporation: 5,602,613 shares worth $110M.
- Woodline Partners added most to TE Connectivity in Q1 2024, an estimated $81.6M increase.
- Woodline Partners's biggest Q1 2024 reduction was AbbVie, cutting an estimated $110M.
- Woodline Partners fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $113M.
- Woodline Partners's ten largest holdings make up 14% of its $10.9B portfolio in Q1 2024.
- Woodline Partners opened 211 new positions and closed 150 in Q1 2024.
- Woodline Partners's portfolio value rose 18% quarter-over-quarter to $10.9B.
Based on Woodline Partners's 13F filing for Q1 2024, filed 15 May 2024.